Bruce D Levy1, Raja-Elie E Abdulnour2, Alexander Tavares2, Thayse R Brüggemann2, Paul C Norris3, Yan Bai2, Xingbin Ai2, Charles N Serhan4. 1. Pulmonary and Critical Care Medicine Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass. Electronic address: blevy@bwh.harvard.edu. 2. Pulmonary and Critical Care Medicine Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass. 3. Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesia, Perioperative and Pain Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass. 4. Center for Experimental Therapeutics and Reperfusion Injury, Department of Anesthesia, Perioperative and Pain Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Mass. Electronic address: cserhan@bwh.harvard.edu.
Abstract
BACKGROUND: Cysteinyl leukotrienes (CysLTs) are potent prophlogistic mediators in asthmatic patients; however, inhibition of CysLT receptor 1 is not a consistently effective treatment, suggesting additional regulatory mechanisms. Other cysteinyl-containing lipid mediators (LMs) derived from docosahexaenoic acid, namely maresin conjugates in tissue regeneration (MCTRs), were recently discovered. Therefore their production and actions in the lung are of considerable interest. OBJECTIVE: We sought to determine MCTR production, bioactions, and mechanisms in the human lung and in patients with experimental allergic airway inflammation. METHODS: LM metabololipidomic profiling of the lung was performed by using liquid chromatography with tandem mass spectrometry. Donor-derived human precision-cut lung slices were exposed to leukotriene (LT) D4, MCTRs, or both before determination of airway contraction. The actions of exogenous MCTRs on murine allergic host responses were determined in the setting of ovalbumin- and house dust mite-induced lung inflammation. RESULTS: Lipidomic profiling showed that the most abundant cysteinyl LMs in healthy human lungs were MCTRs, whereas CysLTs were most prevalent in patients with disease. MCTRs blocked LTD4-initiated airway contraction in human precision-cut lung slices. In mouse allergic lung inflammation MCTRs were present with temporally regulated production. With ovalbumin-induced inflammation, MCTR1 was most potent for promoting resolution of eosinophils, and MCTR3 potently decreased airway hyperreactivity to methacholine, bronchoalveolar lavage fluid albumin, and serum IgE levels. MCTR1 and MCTR3 inhibited lung eosinophilia after house dust mite-induced inflammation. CONCLUSION: These results identified lung MCTRs that blocked human LTD4-induced airway contraction and promoted resolution of murine allergic airway responses when added exogenously. Together, these findings uncover proresolving mechanisms for lung responses that can be disrupted in patients with disease.
BACKGROUND:Cysteinyl leukotrienes (CysLTs) are potent prophlogistic mediators in asthmatic patients; however, inhibition of CysLT receptor 1 is not a consistently effective treatment, suggesting additional regulatory mechanisms. Other cysteinyl-containing lipid mediators (LMs) derived from docosahexaenoic acid, namely maresin conjugates in tissue regeneration (MCTRs), were recently discovered. Therefore their production and actions in the lung are of considerable interest. OBJECTIVE: We sought to determine MCTR production, bioactions, and mechanisms in the human lung and in patients with experimental allergic airway inflammation. METHODS: LM metabololipidomic profiling of the lung was performed by using liquid chromatography with tandem mass spectrometry. Donor-derived human precision-cut lung slices were exposed to leukotriene (LT) D4, MCTRs, or both before determination of airway contraction. The actions of exogenous MCTRs on murineallergic host responses were determined in the setting of ovalbumin- and house dust mite-induced lung inflammation. RESULTS: Lipidomic profiling showed that the most abundant cysteinyl LMs in healthy human lungs were MCTRs, whereas CysLTs were most prevalent in patients with disease. MCTRs blocked LTD4-initiated airway contraction in human precision-cut lung slices. In mouseallergic lung inflammation MCTRs were present with temporally regulated production. With ovalbumin-induced inflammation, MCTR1 was most potent for promoting resolution of eosinophils, and MCTR3 potently decreased airway hyperreactivity to methacholine, bronchoalveolar lavage fluid albumin, and serum IgE levels. MCTR1 and MCTR3 inhibited lung eosinophilia after house dust mite-induced inflammation. CONCLUSION: These results identified lung MCTRs that blocked humanLTD4-induced airway contraction and promoted resolution of murineallergic airway responses when added exogenously. Together, these findings uncover proresolving mechanisms for lung responses that can be disrupted in patients with disease.
Authors: Xavier de la Rosa; Paul C Norris; Nan Chiang; Ana R Rodriguez; Bernd W Spur; Charles N Serhan Journal: Am J Pathol Date: 2018-04 Impact factor: 4.307
Authors: Jesmond Dalli; Iliyan Vlasakov; Ian R Riley; Ana R Rodriguez; Bernd W Spur; Nicos A Petasis; Nan Chiang; Charles N Serhan Journal: Proc Natl Acad Sci U S A Date: 2016-10-06 Impact factor: 11.205
Authors: Hans Bisgaard; Jakob Stokholm; Bo L Chawes; Nadja H Vissing; Elin Bjarnadóttir; Ann-Marie M Schoos; Helene M Wolsk; Tine M Pedersen; Rebecca K Vinding; Sunna Thorsteinsdóttir; Nilofar V Følsgaard; Nadia R Fink; Jonathan Thorsen; Anders G Pedersen; Johannes Waage; Morten A Rasmussen; Ken D Stark; Sjurdur F Olsen; Klaus Bønnelykke Journal: N Engl J Med Date: 2016-12-29 Impact factor: 91.245
Authors: Yan Bai; Nandini Krishnamoorthy; Kruti R Patel; Ivan Rosas; Michael J Sanderson; Xingbin Ai Journal: Am J Respir Cell Mol Biol Date: 2016-05 Impact factor: 6.914
Authors: Thomas W Carion; Yuxin Wang; Ashten Stambersky; Abdul Shukkur Ebrahim; Elizabeth A Berger Journal: J Immunol Date: 2022-04-25 Impact factor: 5.426
Authors: Nan Chiang; Xavier de la Rosa; Stephania Libreros; Hui Pan; Jonathan M Dreyfuss; Charles N Serhan Journal: Proc Natl Acad Sci U S A Date: 2021-03-09 Impact factor: 11.205
Authors: Katherine H Walker; Nandini Krishnamoorthy; Thayse R Brüggemann; Ashley E Shay; Charles N Serhan; Bruce D Levy Journal: Front Immunol Date: 2021-08-19 Impact factor: 7.561
Authors: Florent Artru; Mark J W McPhail; Evangelos Triantafyllou; Francesca Maria Trovato Journal: Front Immunol Date: 2022-03-31 Impact factor: 7.561